LGND logo

Ligand Pharmaceuticals Incorporated (LGND) Short Term Debt

Annual Short Term Debt

$410.00 K
-$77.00 M-99.47%

31 December 2023

LGND Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Short Term Debt

$1.09 M
-$78.00 K-6.68%

30 September 2024

LGND Quarterly Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

LGND Short Term Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-99.5%+119.3%
3 y3 years-95.2%-51.0%
5 y5 years-98.5%+17.7%

LGND Short Term Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-99.5%at low-99.1%+165.8%
5 y5 years-99.5%at low-99.1%+165.8%
alltimeall time-99.8%-99.5%

Ligand Pharmaceuticals Incorporated Short Term Debt History

DateAnnualQuarterly
Sept 2024
-
$1.09 M(-6.7%)
June 2024
-
$1.17 M(+16.5%)
Mar 2024
-
$1.00 M(+144.6%)
Dec 2023
$410.00 K(-99.5%)
$410.00 K(-17.5%)
Sept 2023
-
$497.00 K(-26.9%)
June 2023
-
$680.00 K(-99.1%)
Mar 2023
-
$77.49 M(+0.1%)
Dec 2022
$77.41 M(+5378.4%)
$77.41 M(-2.0%)
Sept 2022
-
$78.99 M(-32.8%)
June 2022
-
$117.53 M(+6079.0%)
Mar 2022
-
$1.90 M(+34.6%)
Dec 2021
$1.41 M(-83.3%)
$1.41 M(-36.5%)
Sept 2021
-
$2.23 M(-4.1%)
June 2021
-
$2.32 M(-69.5%)
Mar 2021
-
$7.61 M(-10.2%)
Dec 2020
$8.48 M(+575.5%)
$8.48 M(+723.9%)
Sept 2020
-
$1.03 M(-40.5%)
June 2020
-
$1.73 M(+16.5%)
Mar 2020
-
$1.48 M(+18.2%)
Dec 2019
$1.25 M(-95.3%)
$1.25 M(+35.5%)
Sept 2019
-
$926.00 K(-96.7%)
June 2019
-
$28.08 M(+0.5%)
Mar 2019
-
$27.94 M(+5.7%)
Dec 2018
$26.43 M(-88.2%)
$26.43 M(-87.6%)
Sept 2018
-
$213.14 M(+1.3%)
June 2018
-
$210.37 M(-7.5%)
Mar 2018
-
$227.55 M(+1.3%)
Dec 2017
$224.53 M(+5.5%)
$224.53 M(+1.3%)
Sept 2017
-
$221.56 M(+1.3%)
June 2017
-
$218.63 M(+1.3%)
Mar 2017
-
$215.75 M(+1.3%)
Dec 2016
$212.91 M(+5.4%)
$212.91 M(+1.3%)
Sept 2016
-
$210.12 M(+1.3%)
June 2016
-
$207.36 M(+2.7%)
Dec 2015
$201.99 M(+2117.4%)
$201.99 M(>+9900.0%)
Mar 2015
-
$348.00 K(+3.3%)
Sept 2014
-
$337.00 K(-87.5%)
June 2014
-
$2.70 M(-53.2%)
Mar 2014
-
$5.77 M(-36.7%)
Dec 2013
$9.11 M(-38.6%)
$9.11 M(-26.4%)
Sept 2013
-
$12.38 M(-9.0%)
June 2013
-
$13.60 M(+2.9%)
Mar 2013
-
$13.21 M(-10.9%)
Dec 2012
$14.84 M(+48.4%)
$14.84 M(+11.9%)
Sept 2012
-
$13.26 M(-13.3%)
June 2012
-
$15.29 M(+150.9%)
Mar 2012
-
$6.10 M(-39.0%)
Dec 2011
$10.00 M(>+9900.0%)
$10.00 M(-44.5%)
Sept 2011
-
$18.03 M(+80.3%)
June 2011
-
$10.00 M(-2.9%)
Mar 2011
-
$10.30 M(>+9900.0%)
Dec 2010
$0.00(-100.0%)
$0.00(-100.0%)
Sept 2010
-
$15.07 M(-23.1%)
June 2010
-
$19.60 M(+328.6%)
Mar 2010
-
$4.57 M(-62.2%)
Sept 2009
-
$12.10 M(+2.9%)
June 2009
-
$11.76 M(+1.8%)
Mar 2009
-
$11.55 M(+531.3%)
DateAnnualQuarterly
Dec 2008
$1.83 M(+19.7%)
$1.83 M(+155.4%)
Sept 2008
-
$716.00 K(-26.8%)
June 2008
-
$978.00 K(-21.0%)
Mar 2008
-
$1.24 M(-19.0%)
Dec 2007
$1.53 M(-96.2%)
$1.53 M(-15.6%)
Sept 2007
-
$1.81 M(-9.0%)
June 2007
-
$1.99 M(-7.5%)
Mar 2007
-
$2.15 M(-94.6%)
Dec 2006
$39.92 M(+1354.2%)
$39.92 M(>+9900.0%)
Sept 2006
-
$363.00 K(-85.5%)
June 2006
-
$2.50 M(-5.5%)
Mar 2006
-
$2.65 M(-3.5%)
Dec 2005
$2.75 M(-6.1%)
$2.75 M(-2.8%)
Sept 2005
-
$2.83 M(-4.9%)
June 2005
-
$2.97 M(-0.2%)
Mar 2005
-
$2.98 M(+1.8%)
Dec 2004
$2.92 M(+18.0%)
$2.92 M(-0.2%)
Sept 2004
-
$2.93 M(+6.3%)
June 2004
-
$2.76 M(+0.5%)
Mar 2004
-
$2.74 M(+10.6%)
Dec 2003
$2.48 M(+18.8%)
$2.48 M(-58.8%)
June 2003
-
$6.02 M(+185.8%)
Mar 2003
-
$2.10 M(+0.9%)
Dec 2002
$2.09 M(-61.1%)
$2.09 M(-76.6%)
Sept 2002
-
$8.91 M(+74.9%)
June 2002
-
$5.09 M(-90.4%)
Mar 2002
-
$53.13 M(+890.0%)
Dec 2001
$5.37 M(+54.3%)
$5.37 M(+110.4%)
Sept 2001
-
$2.55 M(-79.1%)
June 2001
-
$12.23 M(+309.4%)
Mar 2001
-
$2.99 M(-14.1%)
Dec 2000
$3.48 M(-15.2%)
$3.48 M(-10.8%)
Sept 2000
-
$3.90 M(-8.2%)
June 2000
-
$4.25 M(+0.6%)
Mar 2000
-
$4.22 M(+3.0%)
Dec 1999
$4.10 M(+28.1%)
$4.10 M(+10.8%)
Sept 1999
-
$3.70 M(+5.7%)
June 1999
-
$3.50 M(+6.1%)
Mar 1999
-
$3.30 M(+3.1%)
Dec 1998
$3.20 M(+14.3%)
$3.20 M(+3.2%)
Sept 1998
-
$3.10 M(+10.7%)
June 1998
-
$2.80 M(+3.7%)
Mar 1998
-
$2.70 M(-3.6%)
Dec 1997
$2.80 M(+7.7%)
$2.80 M(-3.4%)
Sept 1997
-
$2.90 M(0.0%)
June 1997
-
$2.90 M(+3.6%)
Mar 1997
-
$2.80 M(+7.7%)
Dec 1996
$2.60 M(+8.3%)
$2.60 M(-3.7%)
Sept 1996
-
$2.70 M(+3.8%)
June 1996
-
$2.60 M(-3.7%)
Mar 1996
-
$2.70 M(+12.5%)
Dec 1995
$2.40 M(+84.6%)
$2.40 M(+84.6%)
Sept 1995
-
$1.30 M(0.0%)
Mar 1995
-
$1.30 M(0.0%)
Dec 1994
$1.30 M
$1.30 M(+8.3%)
Sept 1994
-
$1.20 M(0.0%)
June 1994
-
$1.20 M(0.0%)
Mar 1994
-
$1.20 M

FAQ

  • What is Ligand Pharmaceuticals Incorporated annual short term debt?
  • What is the all time high annual short term debt for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated annual short term debt year-on-year change?
  • What is Ligand Pharmaceuticals Incorporated quarterly short term debt?
  • What is the all time high quarterly short term debt for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated quarterly short term debt year-on-year change?

What is Ligand Pharmaceuticals Incorporated annual short term debt?

The current annual short term debt of LGND is $410.00 K

What is the all time high annual short term debt for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high annual short term debt is $224.53 M

What is Ligand Pharmaceuticals Incorporated annual short term debt year-on-year change?

Over the past year, LGND annual short term debt has changed by -$77.00 M (-99.47%)

What is Ligand Pharmaceuticals Incorporated quarterly short term debt?

The current quarterly short term debt of LGND is $1.09 M

What is the all time high quarterly short term debt for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high quarterly short term debt is $227.55 M

What is Ligand Pharmaceuticals Incorporated quarterly short term debt year-on-year change?

Over the past year, LGND quarterly short term debt has changed by +$593.00 K (+119.32%)